KEMET Reports Third Quarter of Fiscal Year 2012 Results

GREENVILLE, S.C., Feb. 2, 2012 /PRNewswire/ -- KEMET Corporation ("KEMET" or the "Company") (NYSE: KEM) today reported preliminary results for the third fiscal quarter ended December 31, 2011.  Net sales for the quarter ended December 31, 2011 were $218.8 million which is a 17.3% decrease over the same quarter last fiscal year. Net sales for the nine months ended December 31, 2011 were $774.2 million which is a 2.3% increase over the same period last fiscal year.

On a U.S. GAAP basis, net loss was $(27.8) million, or $(0.62) per basic and diluted share for the third quarter of fiscal year 2012 compared to net income of $27.2 million or $0.52 per diluted share for the same quarter last year.

Non-GAAP adjusted net income was $2.0 million or $0.04 per diluted share for the third quarter of fiscal year 2012 compared to $33.1 million of adjusted net income or $0.64 per diluted share for the same quarter last year.

"We entered this quarter knowing that the impact of the distribution channel inventory rebalancing would have a significant impact on our financial results", said Per Loof, Chief Executive Officer of KEMET.  "However, we generated approximately $21 million of cash from operations and we were successful in securing one of our key supply sources through the acquisition of Niotan Incorporated.  Even though we expect the next couple of quarters to remain challenging we are positioning the Company for a strong rebound through our continuing realignment of facilities in Europe and supply chain integration when the world economy improves," continued Loof.

On a U.S. GAAP basis, the third quarter of fiscal year 2012 includes a $15.8 million impairment charge related to the Tantalum Business Group.  In addition, the third quarter of fiscal year 2012 includes $10.7 million of restructuring charges primarily comprised of termination benefits of $6.1 million related to planned facility closures in Italy that will commence during fiscal year 2013 and charges of $4.5 million to participate in a plan to save labor costs whereby a company may temporarily "lay off" employees while the government continues to pay their wages for a certain period of time.  This restructuring activity is a continuation of the Company's efforts to restructure its manufacturing operations within Europe, primarily within the Film and Electrolytic segment. Construction has started on a new manufacturing facility in Pontecchio, Italy, that will allow the closure and consolidation of three manufacturing operations located in Italy.  The third quarter of fiscal year 2011 included $1.1 million of restructuring charges primarily associated with the relocation of equipment and $1.0 million of debt and stock registration related fees.

About KEMET

The Company's common stock is listed on the NYSE under the ticker symbol "KEM" (NYSE: KEM).  At the Investor Relations section of our web site at http://ir.kemet.com, users may subscribe to KEMET news releases and find additional information about our Company.  KEMET applies world class service and quality to deliver industry leading, high performance capacitance solutions to its customers around the world and offers the world's most complete line of surface mount and through hole capacitor technologies across tantalum, ceramic, film, aluminum, electrolytic, and paper dielectrics. Additional information about KEMET can be found at http://www.kemet.com.

QUIET PERIOD

Beginning April 1, 2012, we will observe a quiet period during which the information provided in this news release and our quarterly report on Form 10-Q will no longer constitute our current expectations. During the quiet period, this information should be considered to be historical, applying prior to the quiet period only and not subject to update by management. The quiet period will extend until the day when our next quarterly earnings release is published.

CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS

Certain statements included herein contain forward-looking statements within the meaning of federal securities laws about KEMET Corporation's (the "Company") financial condition and results of operations that are based on management's current expectations, estimates and projections about the markets, in which the Company operates, as well as management's beliefs and assumptions. Words such as "expects," "anticipates," "believes," "estimates," variations of such words and other similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's judgment only as of the date hereof. The Company undertakes no obligation to update publicly any of these forward-looking statements to reflect new information, future events or otherwise.

Factors that may cause actual outcome and results to differ materially from those expressed in, or implied by, these forward-looking statements include, but are not necessarily limited to the following:

(i) adverse economic conditions could impact our ability to realize operating plans if the demand for our products declines, and such conditions could adversely affect our liquidity and ability to continue to operate; (ii) adverse economic conditions could cause the write down of long-lived assets; (iii) an increase in the cost or a decrease in the availability of our principal raw materials; (iv) changes in the competitive environment; (v) uncertainty of the timing of customer product qualifications in heavily regulated industries; (vi) economic, political, or regulatory changes in the countries in which we operate; (vii) difficulties, delays or unexpected costs in completing the restructuring plan; (viii) inability to attract, train and retain effective employees and management; (ix) inability to develop innovative products to maintain customer relationships and offset potential price erosion in older products; (x) exposure to claims alleging product defects; (xi) the impact of laws and regulations that apply to our business, including those relating to environmental matters; (xii) volatility of financial and credit markets affecting our access to capital; (xiii) needing to reduce the total costs of our products to remain competitive; (xiv) potential limitation on the use of net operating losses to offset possible future taxable income; (xv) restrictions in our debt agreements that limit our flexibility in operating our business; and (xvi) additional exercise of the warrant by K Equity which could potentially result in the existence of a significant stockholder who could seek to influence our corporate decisions.

Contact:

Dean W. Dimke
Director of Corporate and
Investor Communications
deandimke@kemet.com
954-766-2800

William M. Lowe, Jr.
Executive Vice President and
Chief Financial Officer
williamlowe@kemet.com
864-963-6484

KEMET CORPORATION AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(Amounts in thousands except per share data)

(Unaudited)












Quarters Ended December 31,


Nine Months Ended December 31,





2011


2010


2011


2010












Net sales

$             218,795


$        264,654


$            774,165


$                757,036












Operating costs and expenses:









Cost of sales

178,305


192,132


592,128


553,888


Selling, general and administrative expenses

24,737


27,453


83,368


76,667


Research and development

7,172


6,947


21,620


19,202


Restructuring charges

10,748


1,102


13,378


5,197


Write down of long-lived assets

15,786


-


15,786


-


Net (gain) loss on sales and disposals of assets

9


29


92


(1,406)



Total operating costs and expenses

236,757


227,663


726,372


653,548




Operating income (loss)

(17,962)


36,991


47,793


103,488












Other (income) expense:









Interest income

(62)


(28)


(136)


(133)


Interest expense

7,036


7,756


21,718


22,548


Other (income) expense, net

716


1,471


1,918


(1,647)


Loss on early extinguishment of debt

-


-


-


38,248



Income (loss) before income taxes

(25,652)


27,792


24,293


44,472



Income tax expense

2,119


625


5,897


2,493




Net income (loss)

$             (27,771)


$          27,167


$              18,396


$                  41,979












Net income (loss) per share:








  Basic

$                 (0.62)


$              0.96


$                  0.43


$                      1.53

  Diluted

$                 (0.62)


$              0.52


$                  0.35


$                      0.82












Weighted-average shares outstanding:








  Basic

44,644


28,295


42,834


27,464

  Diluted

44,644


51,960


52,302


51,124



KEMET CORPORATION AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(Amounts in thousands, except per share data)







December 31, 2011


March 31, 2011

ASSETS

(Unaudited)



Current assets:





Cash and cash equivalents

$             136,049


$          152,051


Accounts receivable, net

102,432


150,370


Inventories, net

212,118


206,440


Prepaid expenses and other

23,536


28,097


Deferred income taxes

4,027


5,301




Total current assets

478,162


542,259


Property and equipment, net of accumulated depreciation of $770,259





and $740,773 as of December 31, 2011 and March 31, 2011, respectively

290,045


310,412


Goodwill and intangible assets, net

20,479


20,092


Other assets

12,993


11,546

Total assets

$             801,679


$          884,309





LIABILITIES AND STOCKHOLDERS' EQUITY




Current liabilities:





Current portion of long-term debt

$                 1,219


$            42,101


Accounts payable

71,072


90,997


Accrued expenses

65,073


88,291


Income taxes payable

4,239


4,265




Total current liabilities

141,603


225,654


Long-term debt, less current portion

229,847


231,215


Other non-current obligations

58,113


59,727


Deferred income taxes

6,894


7,960


-


-

Stockholders' equity:





Preferred stock, par value $0.01, authorized 10,000 shares, none issued

-


-


Common stock, par value $0.01, authorized 175,000 and 300,000 shares, issued






46,508 and 39,508 shares, at December 31, 2011 and March 31, 2011, respectively

465


395


Additional paid-in capital

468,646


479,322


Retained deficit

(69,349)


(87,745)


Accumulated other comprehensive income

8,305


22,555


Treasury stock, at cost (1,854 and 2,370 shares at December 31, 2011 and






March 31, 2011, respectively)

(42,845)


(54,774)

Total stockholders' equity

365,222


359,753


-


-

Total liabilities and stockholders' equity

$             801,679


$          884,309



KEMET CORPORATION AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(Amounts in thousands)

(Unaudited)

























Nine Months Ended December 31,







2011


2010

Sources (uses) of cash and cash equivalents





Operating activities:






Net income

$                        18,396


$                        41,979



Adjustments to reconcile net income to net cash provided by







operating activities:







Depreciation and amortization

33,384


41,303




Write down of long-lived assets

15,786


-




Amortization of debt discount and debt issuance costs

2,903


3,964




Net (gain) loss on sales and disposals of assets

92


(1,406)




Stock-based compensation expense

1,378


911




Change in deferred income taxes

909


(1,186)




Change in operating assets

46,330


(64,485)




Change in operating liabilities

(48,116)


17,658




Other

841


(1,885)




Loss on early extinguishment of debt

-


38,248





Net cash provided by operating activities

71,903


75,101











Investing activities:






Capital expenditures

(31,793)


(19,559)



Acquisition, net of cash received

(11,584)


-



Proceeds from sales of assets

-


5,425





Net cash used in investing activities

(43,377)


(14,134)











Financing activities:






Proceeds from issuance of debt

-


227,525



Payments of long-term debt

(40,581)


(230,300)



Net payments under other credit facilities

(3,153)


(2,626)



Proceeds from exercise of stock options

225


21



Debt issuance costs

(36)


(7,750)



Debt extinguishment costs

-


(207)





Net cash used in financing activities

(43,545)


(13,337)






Net increase (decrease) in cash and cash equivalents

(15,019)


47,630


Effect of foreign currency fluctuations on cash

(983)


943


Cash and cash equivalents at beginning of fiscal period

152,051


79,199


Cash and cash equivalents at end of fiscal period

$                      136,049


$                      127,772



Non-U.S. GAAP Financial Measures

In this news release, the Company makes reference to certain Non-U.S. GAAP financial measures, including "Adjusted net income", "Adjusted net income per share" and "Adjusted EBITDA".  Management believes that investors may find it useful to review the Company's financial results as adjusted to exclude items as determined by management.

Adjusted Net Income and Adjusted Net Income Per Share

"Adjusted net income" and "Adjusted net income per share" represent net income and net income per share excluding write down of long-lived assets, restructuring charges related primarily to equipment moves and employee severance, plant start-up costs, amortization related to debt issuance costs and debt discount, net gain/loss on sales and disposals of assets, ERP integration costs, stock-based compensation expense/recovery, net foreign exchange loss, registration related fees, acquisition related fees, gain on licensing of patents, loss on early extinguishment of debt, income tax expense related to foreign tax law changes which limit the utilization of net operating losses, and income tax effect on non-GAAP adjustments.  Management believes that these Non-U.S. GAAP financial measures are useful to investors because they provide a supplemental way to understand the underlying operating performance of the Company.  Management uses these Non-U.S. GAAP financial measures to evaluate operating performance.  Non-U.S. GAAP financial measures should not be considered as an alternative to net income, operating income or any other performance measures derived in accordance with U.S. GAAP.

The following table provides reconciliation from U.S. GAAP net income (loss) to Non-U.S. GAAP adjusted net income:

GAAP to Non-GAAP Reconciliation



Quarters Ended


Nine Months Ended December 31,



December 31, 2011


September 30, 2011


December 31, 2010


2011


2010



(Unaudited) (Amounts in thousands, except per share data)












Net sales 


$                     218,795


$                     265,514


$                       264,654


$         774,165


$          757,036












Net income (loss)


$                     (27,771)


$                       14,318


$                         27,167


$           18,396


$            41,979

Basic net income (loss) per share 


$                         (0.62)


$                           0.32


$                             0.96


$               0.43


$                1.53

Diluted net income (loss) per share


$                         (0.62)


$                           0.27


$                             0.52


$               0.35


$                0.82












 Excluding the following items (Non-GAAP) 






















Net income (loss) 


$                     (27,771)


$                       14,318


$                         27,167


$           18,396


$            41,979

    Adjustments: 











         Write down of long-lived assets 


15,786


-


-


15,786


-

         Restructuring charges  


10,748


1,605


1,102


13,378


5,197

         Plant start-up costs 


666


718


-


1,384


-

         Amortization included in interest expense 


847


1,012


1,210


2,903


3,964

         Net (gain) loss on sales and disposals of assets 


9


(40)


29


92


(1,406)

         ERP integration costs 


1,812


1,918


602


4,935


1,257

         Stock-based compensation expense (recovery) 


(797)


984


429


1,378


911

         Net foreign exchange loss


303


1,391


1,785


1,571


378

         Registration related fees 


-


77


950


281


950

         Acquisition related fees 


-


-


-


610


-

         Gain on licensing of patents


-


-


-


-


(2,000)

         Loss on early extinguishment of debt 


-


-


-


-


38,248

         Income tax expense related to foreign tax law changes 


1,448


-


-


1,448


-

         Income tax effect of non-GAAP adjustments (1) 


(1,050)


406


(196)


(660)


(828)

 Adjusted net income 


$                         2,001


$                       22,389


$                         33,078


$           61,502


$            88,650











Adjusted net income per share (excluding adjustments): 











         Basic 


$                           0.04


$                           0.50


$                             1.17


$               1.44


$                3.23

         Diluted 


$                           0.04


$                           0.43


$                             0.64


$               1.18


$                1.73












Weighted-average shares outstanding:











         Basic 


44,644


44,370


28,295


42,834


27,464

         Diluted 


52,209


52,230


51,960


52,302


51,124


































(1)  The income tax effect of the excluded items is calculated by applying the applicable jurisdictional income tax rate, considering the deferred tax valuation for each applicable jurisdiction.




Adjusted EBITDA

Adjusted EBITDA represents net income (loss) before income tax expense, net interest expense, and depreciation and amortization expense, adjusted to exclude: write down of long-lived assets, restructuring charges, plant start-up costs, net foreign exchange loss, stock-based compensation expense/recovery, gain/loss on sales and disposals of assets, ERP integration costs, registration related fees, acquisition related fees, gain on licensing of patents, and loss on early extinguishment of debt.  We use Adjusted EBITDA to monitor and evaluate our operating performance and to facilitate internal and external comparisons of the historical operating performance of our business.  We present Adjusted EBITDA as a supplemental measure of our performance and ability to service debt.  We also present Adjusted EBITDA because we believe such measure is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry.

We believe Adjusted EBITDA is an appropriate supplemental measure of debt service capacity, because cash expenditures on interest are, by definition, available to pay interest, and tax expense is inversely correlated to interest expense because tax expense goes down as deductible interest expense goes up; depreciation and amortization are non-cash charges. The other items excluded from Adjusted EBITDA are excluded in order to better reflect our continuing operations.

In evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses similar to the adjustments noted below.  Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these types of adjustments.  Adjusted EBITDA is not a measurement of our financial performance under U.S. GAAP and should not be considered as an alternative to net income, operating income or any other performance measures derived in accordance with U.S. GAAP or as an alternative to cash flow from operating activities as a measure of our liquidity.

Our Adjusted EBITDA measure has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under U.S. GAAP.  Some of these limitations are:

  • it does not reflect our cash expenditures, future requirements for capital expenditures or contractual commitments;

  • it does not reflect changes in, or cash requirements for, our working capital needs;

  • it does not reflect the significant interest expense or the cash requirements necessary to service interest or principal payment on our debt;

  • although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and our Adjusted EBITDA measure does not reflect any cash requirements for such replacements;

  • it is not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows;

  • it does not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations;

  • it does not reflect limitations on or costs related to transferring earnings from our subsidiaries to us; and

  • other companies in our industry may calculate this measure differently than we do, limiting its usefulness as a comparative measure.

Because of these limitations, Adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business or as a measure of cash that will be available to us to meet our obligations.  You should compensate for these limitations by relying primarily on our U.S. GAAP results and using Adjusted EBITDA only supplementally.

The following table provides a reconciliation from U.S. GAAP net income (loss) to Adjusted EBITDA (amounts in thousands):


Quarters Ended December 31,


Nine Months Ended December 31,


2011


2010


2011


2010

Net income (loss)

$         (27,771)


$       27,167


$         18,396


$           41,979









Adjustments:








Income tax expense

2,119


625


5,897


2,493

Interest expense, net

6,974


7,728


21,582


22,415

Depreciation and amortization

10,373


12,661


33,384


41,303

Write down of long-lived assets

15,786


-


15,786


-

Restructuring charges

10,748


1,102


13,378


5,197

Plant start-up costs

666


-


1,384


-

Net foreign exchange loss

303


1,785


1,571


378

Stock-based compensation expense (recovery)

(797)


429


1,378


911

Net (gain) loss on sales and disposals of assets

9


29


92


(1,406)

ERP integration costs

1,812


602


4,935


1,257

Registration related fees

-


950


281


950

Acquisition related fees

-


-


610


-

Gain on licensing of patents

-


-


-


(2,000)

Loss on early extinguishment of debt

-


-


-


38,248









Adjusted EBITDA

$           20,222


$       53,078


$       118,674


$         151,725



SOURCE KEMET Corporation